Showing results (801-810 of 944) with videos related to
Sort By:
Pageof 95
Neurology and Therapy|April 18, 2023
Optimizing The Timing of Stereotactic Minimally Invasive Drainage for Hypertensive Intracerebral HemorrhageJingchen Li, Zhiyong Li, Lin Zhao, et al.Neurology and Therapy|April 3, 2023
A Path to Improved Alzheimer's Care: Simulating Long-Term Health Outcomes of Lecanemab in Early Alzheimer's Disease from the CLARITY AD TrialAmir Abbas Tahami Monfared, Weicheng Ye, Aditya Sardesai, et al.Neurology and Therapy|August 12, 2020
Maintenance Intravenous Immunoglobulin Treatment for Multiple Sclerosis Coexisting with Ehlers-Danlos Syndrome and Muir-Torre Syndrome: A Case StudySrishti Gupta, Mohnish Suri, Cris S ConstantinescuNeurology and Therapy|August 14, 2020
A Review of Patisiran (ONPATTRO®) for the Treatment of Polyneuropathy in People with Hereditary Transthyretin AmyloidosisIvan Urits, Daniel Swanson, Michael C Swett, et al.Neurology and Therapy|April 24, 2021
The Association Between Dietary Acid Load and Odds of Migraine: A Case-Control SurveyMaryam Mousavi, Soodeh Razeghi Jahromi, Mansoureh Togha, et al.Neurology and Therapy|April 20, 2021
Patient and Provider Insights into the Impact of Multiple Sclerosis on Mental Health: A Narrative ReviewBryan E Davis, Lynsey Lakin, Cherie C Binns, et al.Neurology and Therapy|April 15, 2021
The COVID-19 Pandemic Experience in Multiple Sclerosis: The Good, the Bad and the NeutralHannah Morris-Bankole, Aileen K HoNeurology and Therapy|April 9, 2021
Treatment Satisfaction of Galcanezumab in Japanese Patients with Episodic Migraine: A Phase 2 Randomized Controlled StudyYoshihisa Tatsuoka, Takao Takeshima, Akichika Ozeki, et al.Neurology and Therapy|May 12, 2023
Intravenous Immunoglobulin Treatment Patterns and Outcomes in Patients with Chronic Inflammatory Demyelinating Polyradiculoneuropathy: A US Claims Database AnalysisColin Anderson-Smits, Mary E Ritchey, Zhongwen Huang, et al.Neurology and Therapy|May 15, 2023
Predicting the Societal Value of Lecanemab in Early Alzheimer's Disease in Japan: A Patient-Level SimulationAtaru Igarashi, Mie Kasai Azuma, Quanwu Zhang, et al.Pageof 95